Kellanova
Kellanova (K) Financial Performance & Income Statement Overview
Analyze Kellanova (K) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Kellanova (K) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Kellanova K financial performance.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $3.20B | $3.08B | $3.12B | $3.23B |
| Cost of Revenue | $0.00 | $2.02B | $1.96B | $2.06B |
| Gross Profit | $0.00 | $1.06B | $1.16B | $1.18B |
| Gross Profit Ratio | $0.00 | $0.34 | $0.37 | $0.36 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $652.00M | $650.00M | $631.00M | $718.00M |
| Operating Expenses | $652.00M | $650.00M | $631.00M | $718.00M |
| Total Costs & Expenses | $0.00 | $2.67B | $2.59B | $2.77B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $63.00M | $65.00M | $90.00M | $75.00M |
| Depreciation & Amortization | $0.00 | $92.00M | $94.00M | $92.00M |
| EBITDA | $438.00M | $535.00M | $641.00M | $569.00M |
| EBITDA Ratio | $0.14 | $0.17 | $0.21 | $0.18 |
| Operating Income | $438.00M | $413.00M | $531.00M | $460.00M |
| Operating Income Ratio | $0.14 | $0.13 | $0.17 | $0.14 |
| Other Income/Expenses (Net) | -$54.00M | -$32.00M | -$72.00M | -$56.00M |
| Income Before Tax | $384.00M | $381.00M | $459.00M | $404.00M |
| Income Before Tax Ratio | $0.12 | $0.12 | $0.15 | $0.12 |
| Income Tax Expense | $85.00M | $73.00M | $91.00M | $34.00M |
| Net Income | $299.00M | $304.00M | $365.00M | $367.00M |
| Net Income Ratio | $0.09 | $0.10 | $0.12 | $0.11 |
| EPS | $0.86 | $0.88 | $1.06 | $1.07 |
| Diluted EPS | $0.85 | $0.87 | $1.04 | $1.05 |
| Weighted Avg Shares Outstanding | $347.00M | $346.00M | $345.00M | $343.00M |
| Weighted Avg Shares Outstanding (Diluted) | $350.00M | $349.00M | $350.00M | $347.00M |
The company's financials show resilient growth, with revenue advancing from $3.23B in Q3 2024 to $3.20B in Q2 2025. Gross profit remained healthy with margins at N/A in Q2 2025 compared to 36% in Q3 2024. Operating income hit $438.00M last quarter, sustaining a consistent 14% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $438.00M. Net income dropped to $299.00M, while earnings per share reached $0.86. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan